UBS Group’s iShares US Healthcare ETF IYH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $173M | Buy |
2,577,753
+52,369
| +2% | +$3.28M | 0.02% | 750 |
|
|
2026
Q1 | $156M | Buy |
2,525,384
+1,325,038
| +110% | +$85.6M | 0.02% | 748 |
|
|
2025
Q4 | $78.1M | Sell |
1,200,346
-43,025
| -3% | -$2.71M | 0.01% | 1220 |
|
|
2025
Q3 | $73M | Buy |
1,243,371
+122,982
| +11% | +$7M | 0.01% | 1277 |
|
|
2025
Q2 | $63.3M | Sell |
1,120,389
-193,111
| -15% | -$10.9M | 0.01% | 1302 |
|
|
2025
Q1 | $80M | Sell |
1,313,500
-58,534
| -4% | -$3.58M | 0.01% | 1080 |
|
|
2024
Q4 | $79.9M | Sell |
1,372,034
-104,678
| -7% | -$6.47M | 0.01% | 1062 |
|
|
2024
Q3 | $96M | Sell |
1,476,712
-5,297
| -0.4% | -$338K | 0.02% | 743 |
|
|
2024
Q2 | $90.8M | Sell |
1,482,009
-12,497
| -0.8% | -$752K | 0.02% | 695 |
|
|
2024
Q1 | $92.5M | Sell |
1,494,506
-26,964
| -2% | -$1.62M | 0.02% | 684 |
|
|
2023
Q4 | $87.1M | Buy |
1,521,470
+72,355
| +5% | +$3.94M | 0.03% | 647 |
|
|
2023
Q3 | $78.3M | Sell |
1,449,115
-39,525
| -3% | -$2.21M | 0.03% | 601 |
|
|
2023
Q2 | $83.4M | Buy |
1,488,640
+5,670
| +0.4% | +$315K | 0.03% | 569 |
|
|
2023
Q1 | $81M | Sell |
1,482,970
-264,345
| -15% | -$14.5M | 0.03% | 543 |
|
|
2022
Q4 | $99.1M | Buy |
1,747,315
+36,925
| +2% | +$2.04M | 0.04% | 496 |
|
|
2022
Q3 | $86.5M | Buy |
1,710,390
+239,540
| +16% | +$12.9M | 0.04% | 477 |
|
|
2022
Q2 | $79.1M | Buy |
1,470,850
+60,555
| +4% | +$3.32M | 0.03% | 528 |
|
|
2022
Q1 | $81.5M | Buy |
1,410,295
+44,235
| +3% | +$2.47M | 0.03% | 593 |
|
|
2021
Q4 | $82.1M | Buy |
1,366,060
+14,620
| +1% | +$835K | 0.02% | 686 |
|
|
2021
Q3 | $74.6M | Buy |
1,351,440
+212,155
| +19% | +$12.1M | 0.02% | 661 |
|
|
2021
Q2 | $62.2M | Sell |
1,139,285
-48,365
| -4% | -$2.56M | 0.02% | 731 |
|
|
2021
Q1 | $60M | Sell |
1,187,650
-117,970
| -9% | -$5.93M | 0.02% | 736 |
|
|
2020
Q4 | $64.2M | Buy |
1,305,620
+43,580
| +3% | +$2.06M | 0.02% | 670 |
|
|
2020
Q3 | $57.3M | Sell |
1,262,040
-37,000
| -3% | -$1.67M | 0.02% | 597 |
|
|
2020
Q2 | $56M | Sell |
1,299,040
-14,990
| -1% | -$633K | 0.02% | 554 |
|
|
2020
Q1 | $49.4M | Buy |
1,314,030
+285,845
| +28% | +$11.8M | 0.02% | 542 |
|
|
2019
Q4 | $44.4M | Sell |
1,028,185
-19,595
| -2% | -$791K | 0.02% | 844 |
|
|
2019
Q3 | $39.6M | Sell |
1,047,780
-177,650
| -14% | -$6.84M | 0.02% | 811 |
|
|
2019
Q2 | $47.9M | Buy |
1,225,430
+34,320
| +3% | +$1.3M | 0.02% | 689 |
|
|
2019
Q1 | $46.2M | Buy |
1,191,110
+21,910
| +2% | +$832K | 0.02% | 674 |
|
|
2018
Q4 | $42.3M | Sell |
1,169,200
-96,605
| -8% | -$3.7M | 0.02% | 669 |
|
|
2018
Q3 | $51.4M | Buy |
1,265,805
+120,720
| +11% | +$4.66M | 0.02% | 662 |
|
|
2018
Q2 | $40.8M | Buy |
1,145,085
+46,500
| +4% | +$1.64M | 0.02% | 753 |
|
|
2018
Q1 | $37.9M | Sell |
1,098,585
-382,655
| -26% | -$13.8M | 0.02% | 774 |
|
|
2017
Q4 | $51.6M | Buy |
1,481,240
+56,015
| +4% | +$1.94M | 0.02% | 651 |
|
|
2017
Q3 | $49M | Buy |
1,425,225
+52,770
| +4% | +$1.78M | 0.02% | 600 |
|
|
2017
Q2 | $45.6M | Sell |
1,372,455
-294,935
| -18% | -$9.42M | 0.02% | 598 |
|
|
2017
Q1 | $51.9M | Buy |
1,667,390
+64,380
| +4% | +$1.96M | 0.03% | 533 |
|
|
2016
Q4 | $46.2M | Buy |
1,603,010
+323,915
| +25% | +$9.39M | 0.03% | 588 |
|
|
2016
Q3 | $38.4M | Buy |
1,279,095
+87,625
| +7% | +$2.68M | 0.02% | 629 |
|
|
2016
Q2 | $35.3M | Sell |
1,191,470
-22,630
| -2% | -$661K | 0.02% | 639 |
|
|
2016
Q1 | $34.1M | Sell |
1,214,100
-72,500
| -6% | -$2.01M | 0.02% | 610 |
|
|
2015
Q4 | $38.6M | Buy |
1,286,600
+45,995
| +4% | +$1.37M | 0.03% | 608 |
|
|
2015
Q3 | $34.7M | Buy |
1,240,605
+55,685
| +5% | +$1.73M | 0.02% | 611 |
|
|
2015
Q2 | $37.6M | Buy |
1,184,920
+73,165
| +7% | +$2.3M | 0.03% | 631 |
|
|
2015
Q1 | $34.3M | Sell |
1,111,755
-116,305
| -9% | -$3.51M | 0.02% | 666 |
|
|
2014
Q4 | $35.4M | Buy |
+1,228,060
| New | +$34.6M | 0.02% | 687 |
|
Other funds holding IYH
PCH
OC
UBS Group's IYH Position: Q2 2026 in Review
UBS Group increased its iShares US Healthcare ETF (IYH) stake by 2.1% in Q2 2026, buying an estimated $3.28M and bringing the position to 2,577,753 shares worth $173M. The position accounts for 0.02% of the portfolio, ranked #750.
UBS Group first reported a position in IYH in Q4 2014 and has held it in 47 quarters since. 529 funds tracked by Wall St. Rank hold IYH as of Q2 2026.
- UBS Group held 2,577,753 shares of iShares US Healthcare ETF worth $173M as of Q2 2026.
- UBS Group bought 52,369 iShares US Healthcare ETF shares in Q2 2026, an estimated $3.28M.
- iShares US Healthcare ETF made up 0.02% of UBS Group's portfolio in Q2 2026, its #750 holding.
- UBS Group first reported a position in iShares US Healthcare ETF in Q4 2014 and has held it in 47 quarters since.
- 529 funds tracked by Wall St. Rank held iShares US Healthcare ETF as of Q2 2026.
Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.